Illumina Stock Price and Value Analysis

Should you buy Illumina stock? (NasdaqGS:ILMN). Let's see how it does in our automated value investing analysis system.

  • This company has stable growth.
  • This company is less known than others.
  • This stock looks overpriced.
  • This company is making money at a modest rate.
  • This company pays no dividend.

ILMN Free Cash Flow Trend

Based on historical returns, we believe that Illumina can grow its free cash at a rate of about 4%. That's positive!

Free Cash Flow trendline for ILMN
Free Cash Flow trendline for Illumina

Inside the ILMN Numbers

ILMN Price
(Illumina stock price per share)
[?] ILMN Fair Price
(based on intrinsic value)
[?] ILMN Safety Price (based on a variable margin of safety) $25.86
[?] PE Ratio versus Sector 129% higher than other Healthcare stocks
[?] PE Ratio versus Industry 19% lower than other Biotechnology stocks
[?] Cash Yield 1.75%
[?] Free Cash Flow Jitter 23%

Is Illumina Stock on Sale?

We believe that Illumina may be worth examining further. It's making money, which is a very positive sign. Is it on sale?

Illumina looks overpriced right now. If you're looking for a bargain in the stock market, you should probably look elsewhere for a great deal. This might still be a great stock to own—but it's not on sale right now.

Should You Buy ILMN Stock?

Does Illumina have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.